PERENNIAL ALLERGIC RHINITIS (PAR)

Clinical trials for PERENNIAL ALLERGIC RHINITIS (PAR) explained in plain language.

Never miss a new study

Get alerted when new PERENNIAL ALLERGIC RHINITIS (PAR) trials appear

Sign up with your email to follow new studies for PERENNIAL ALLERGIC RHINITIS (PAR), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug trial aims to tame Year-Round allergy misery

Symptom relief Recruiting now

This study is testing whether an investigational drug called lebrikizumab can safely reduce nasal symptoms and improve daily life for adults with perennial allergic rhinitis (year-round allergies). About 450 participants will be randomly assigned to receive either lebrikizumab or…

Matched conditions: PERENNIAL ALLERGIC RHINITIS (PAR)

Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Symptom relief

Last updated Mar 30, 2026 14:31 UTC

PERENNIAL ALLERGIC RHINITIS (PAR)

Get alerted when new PERENNIAL ALLERGIC RHINITIS (PAR) trials appear

New drug trial aims to tame Year-Round allergy misery